Zhi Hong, Brii Biosciences CEO

August 25, 2021 06:25 AM EDT

Another Covid-19 antibody cocktail on the menu? Brii Bio touts early win in NIH study for a combo already used in China

Amber Tong

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

view job offer post your job now

TRENDING NOW

Lilly shuffles key executive positions; Mikael Dolsten takes another post-Pfizer assignment

Revolution’s KRAS drugs appear competitive in several lung cancer settings

Iovance stock plummets after lowered full-year guidance, missed analyst expectations for Amtagvi

From deal to disaster: Drugmakers face a changed Washington as Trump embraces ‘most favored nation’ prices

AstraZeneca reports Phase 3 win for Imfinzi; Roche to build new manufacturing site in China

sponsored

In one of the riskiest industries — Biotech — a surefire way to neutralize some of that risk emerges